Latest News
-
PrevANZ Findings
On 6th June 2011 the Foundation was pleased to announce we had joined forces with the MS Society Western Australia to provide vital funding to initiate a world-first clinical trial of Vitamin D for the prevention of MS. This Project could not have proceeded without the contributions of the Trish Foundation and the MS Society…
-
Industry funding attracted
Commencing January 2020, A/Prof Anneke van der Walt was awarded a three-year Trish Translational Research Project Grant titled, “Active Participatory Health Monitoring in people with Multiple Sclerosis (Active-MS)”. The aim of the Project is to implement and validate novel tests that can be used to predict, early on, if patients with MS are likely to…
-
Potential to promote repair
Despite the disruptions and challenges of the past two years, Dr Steven Petratos continues to make exceptional progress with his Trish Translational Research Project which commenced January 2020. Animal models of multiple sclerosis (MS) are vitally important for the understanding of how brain cells die during disease progression and how specific molecules can be targeted…
-
Developing a therapy for MS
Professor Trevor Kilpatrick continues to make excellent progress with his Trish Translational Research Project which commenced January 2020. The aim of Professor Kilpatrick’s project is to develop a therapy for MS based on using immune cells from the blood of patients with MS. These immune cells are treated with anti-inflammatory signals in the laboratory and…
-
PrevANZ Platform Program
The Trish MS Research Foundation contributed $200,000 to the PrevANZ Platform Program to assist the commencement of this very important trial. The vitamin D MS Prevention Trial – PrevANZ is a world-first clinical trial that is testing whether vitamin D supplementation can prevent MS in those at risk of developing the disease. It is a…
-
Postgraduate Scholarship
In 2019 Dr Justin Garber, The University of Sydney, was awarded a three-year Postgraduate Scholarship fully funded by the Trish Foundation. Dr Garber continues to make good progress. Some refinements to the original research proposal have been made, including focusing on the motor system of the brain and measuring damage of MS lesions. Dr Garber…
-
Enhancing Myelin repair
The Foundation has been contributing to a Project Grant titled “Enhancing Myelin repair in multiple sclerosis” at the Florey Institute of Neuroscience and Mental Health, VIC, led by Professor Trevor Kilpatrick. In multiple sclerosis (MS) the protective sheath around nerves, known as myelin, is damaged and lost. This loss disrupts electrical impulses and exposes nerves…
-
Targeting Progressive MS
In January 2020 Dr Steven Petratos was awarded a 3-year Trish Translational Research Project Grant titled, “Development of a small molecule to promote neuroprotection and repair in progressive multiple sclerosis”. Dr Petratos and his team are working on developing a new drug for progressive multiple sclerosis and, despite some barriers with lockdowns in Melbourne and…
-
Dendritic cell therapy for MS
In January 2020, Professor Trevor Kilpatrick, Florey Institute of Neuroscience and Mental Health, was awarded a 3-year Trish Translational Research Project Grant titled, “Dendritic cell therapy for multiple sclerosis”. Most current treatments for MS broadly suppress the immune system, but this can increase risks of infections and cancers. A more targeted approach is to dampen…
-
Making Vitamin D work for MS
In January 2020 Dr Grant Parnell was awarded a Project Grant over three years fully funded by the Trish MS Research Foundation, his Co-Investigator being Professor David Booth. Dr Parnell’s Research Project, ‘Defining how vitamin D promotes tolerogenic dendritic cells to enable its use in combined therapy’, looks at making Vitamin D work for MS.…